Intas Pharmaceuticals Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Atorvastatin Export Records India — #1 Exporter, 328 Shipments, $16.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Intas Pharmaceuticals Limited — Atorvastatin Exporter #1 | $16.4M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Atorvastatin · $16.4M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Atorvastatin with $16.4M in export value and 328 verified shipments. Intas Pharmaceuticals Limited holds a 1.5% market share in Atorvastatin exports across 10 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Atorvastatin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Atorvastatin?

Country	Value	Shipments	Share
CANADA	$2.5M	108	51.0%
NETHERLANDS	$1.8M	113	37.2%
UNITED STATES	$190.9K	4	3.9%
GREECE	$137.2K	12	2.8%
ZIMBABWE

Who Are the Top Buyers of Atorvastatin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	MALTA	$629.5K	59
BIOMEDPHARMA	CANADA	$594.2K	16
BROCACEF NL : HUB	NETHERLANDS	$574.0K	45
ACCORD HEALTHCARE INC.,	CANADA	$374.5K	17
ACCORD HEALTHCARE INC.	CANADA	$337.0K	27
BIOMEDPHARMA 9450 BOUL LANGELIER	CANADA	$219.8K	6
NORA PHARMA INC	CANADA	$205.8K	6
ACCORD HEALTHCARE INC	CANADA	$193.7K	14
NORA PHARMA INC.	CANADA	$193.6K	9
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$190.9K	4

Intas Pharmaceuticals Limited supplies Atorvastatin to 34 buyers globally. The largest buyer is TO THE ORDER (MALTA), followed by BIOMEDPHARMA (CANADA) and BROCACEF NL : HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atorvastatin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI ATORVASTATIN 80MG 10	$229.7K	12
PHARMACEUTICAL DRUGS AND MEDICINE ATORVASTATIN 10MG10X10T G1 ACO GERMANY ASPER INVOICE	$171.8K	10
PHARMA DRUGS AND MEDI BIO ATORVASTATIN 20MG AS PER INVNOS	$149.5K	3
PHARMA DRUGS & MEDI ATORVASTATIN 80MG 10X10T(ACCORD-FI/SE AS PER INVOICE	$137.2K	7
PHARM DRUG&MED:ATORVASTATIN 20MG 10X10T(ACCORD-FI/SE) EACH FILM-COATED TABLET CONTAINS 20 MG ATORVASTATIN	$103.3K	3
PHARMA DRUGS AND MEDI BIO ATORVASTATIN 20MG AS PER INV	$101.0K	3
PHARMA DRUGS & MEDI ATORVASTATIN CAL USP	$100.0K	2
PHARMA DRUGS AND MEDI BIO ATORVASTATIN 40MG 500TBIOMED#CAN AS PER INV	$100.0K	2
PH.DRU.& MED.: BIO ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[1X500T PER PACK]	$100.0K	2
PHARMA DRUG&MED:ATORVASTATIN 20MG 10X10T	$87.1K	4

Intas Pharmaceuticals Limited exports 193 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI ATORVASTATIN 80MG 10 with 12 shipments worth $229.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	PIRAMAL PHARMA LIMITED	$21.4M	429	1	$50.0K
3	MYLAN LABORATORIES LIMITED	$16.5M	330	7	$50.0K
1	INTAS PHARMACEUTICALS LIMITED ★	$16.4M	328	10	$50.0K
10	MEDREICH LIMITED	$14.6M	291	6	$50.0K
5	ALKEM LABORATORIES LIMITED	$13.8M	277	5	$50.0K

Intas Pharmaceuticals Limited ranks #1 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are PIRAMAL PHARMA LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Atorvastatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 421 individual customs records matching Intas Pharmaceuticals Limited exporting Atorvastatin, covering 193 formulations to 12 countries via 34 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Intas Pharmaceuticals Limited — Atorvastatin Exporter Profile

Intas Pharmaceuticals Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from Intas Pharmaceuticals Limited?

What Is India's Total Atorvastatin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Atorvastatin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Atorvastatin Exporters?

What Atorvastatin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

Canada — HC

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Intas Pharmaceuticals Limited Export?

Atorvastatin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Atorvastatin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Intas Pharmaceuticals Limited

Atorvastatin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source